Samsung C&T Shares Rise Over 5% Amid Revaluation Expectations

 
Samsung C&T shares surged more than 5% in early trading, driven by expectations of a revaluation of the company's value due to rising equity values of major affiliates, including Samsung Electronics.
 
According to the Korea Exchange, as of 9:35 a.m. on June 22, Samsung C&T shares were trading at 518,000 won, up 26,500 won (5.39%) from the previous trading day.
 
Hankook Securities reported that the equity values of key affiliates, including a 5.0% stake in Samsung Electronics, a 43.1% stake in Samsung Biologics, and a 19.3% stake in Samsung Life, amount to approximately 159 trillion won. Additionally, the real estate value is estimated at around 7 trillion won, supporting the company's asset value and overall corporate valuation.
 
Park Jong-ryul, a researcher at Hankook Securities, stated, "Considering the rising equity values of Samsung Electronics, Samsung Life, Samsung Biologics, and Samsung SDS, we are adjusting our target price upward."
 
He added, "Since April, the equity values of affiliates like Samsung Electronics and Samsung Life have rapidly increased, accelerating the revaluation of Samsung C&T's stock. The strong performance momentum and expanded shareholder returns suggest that this revaluation is likely to continue."
 
Hankook Securities also highlighted that Samsung C&T is accelerating its business portfolio transition, focusing on four growth pillars: nuclear power, renewable energy, data centers, and biotechnology. The company is securing long-term growth drivers through the expansion of the energy value chain, renewable energy operations, small modular reactors (SMR), and battery energy storage systems (BESS).